Literature DB >> 1620724

Effects of calcium channel blockers on formalin-induced nociception and inflammation in rats.

H Gürdal1, Y Sara, F C Tulunay.   

Abstract

The possible anti-inflammatory and antinociceptive effects of nitrendipine, nicardipine, diltiazem and verapamil were examined with formalin test in the rat paw. Pretreatment with these calcium channel blockers 1 h before formalin injection diminished formalin-induced inflammatory changes and nociceptive responses. Formalin-induced nociceptive responses were inhibited 20-90% by the calcium channel blockers. Nitrendipine and nicardipine were found to be highly effective in inhibiting the inflammatory changes, whereas the effects of verapamil and diltiazem were partial. Administration of naloxone affected neither the inflammatory changes and nociceptive responses induced by formalin nor the antiinflammatory and antinociceptive effects of the calcium channel blockers. The results suggest the possible anti-inflammatory and naloxone-insensitive antinociceptive properties of calcium channel blockers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620724     DOI: 10.1159/000138932

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study.

Authors:  J Twidwell; L Levine
Journal:  Int J Impot Res       Date:  2015-12-24       Impact factor: 2.896

Review 2.  Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection.

Authors:  Jessie I Luoma; Christopher M Stern; Paul G Mermelstein
Journal:  J Steroid Biochem Mol Biol       Date:  2011-11-12       Impact factor: 4.292

3.  Role of opioid system in verapamil-induced antinociception in a rat model of orofacial pain.

Authors:  Esmaeal Tamaddonfard; Amir Erfanparast; Mina Taati; Milad Dabbaghi
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.